英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Calothorax查看　Calothorax　在百度字典中的解释百度英翻中〔查看〕
Calothorax查看　Calothorax　在Google字典中的解释Google英翻中〔查看〕
Calothorax查看　Calothorax　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult . . .
    Inclusion Criteria 1 18 to 80 years of age inclusive, at the time of signing the informed consent 2 Treated with medium-high dose ICS in combination with LABA at a stable dose for at least 28 days prior to Visit 1 Note: EU participants must be treated with high dose ICS in combination with LABA at a stable dose for at least 28 days prior
  • AZD4604 in Asthma - Clinical Trials Registry - ICH GCP
    Exclusion Criteria: A severe asthma exacerbation within 8 weeks prior to randomisation History of herpes zoster reactivation Participants with a significant COVID-19 illness within 6 months of enrolment Clinically important pulmonary disease other than asthma
  • Inclusion and Exclusion Criteria in Clinical Trials
    Understand inclusion and exclusion criteria in clinical trials and why they are vital for participant safety and study integrity Learn how these guidelines determine who can and cannot participate, focusing on factors like age, disease stage, and pre-existing conditions
  • Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation . . .
    Inclusion Criteria - Documented physician-diagnosed asthma ≥ 12 months prior to screening (Visit 1) - Participants treated with medium-to-high dose ICS in combination with LABA at a stable dose for at least 2 months prior to Visit 1 (the ICS can be contained within an ICS-LABA fixed dose combination product or as separate inhaled products
  • AZD4604 and Genuair and Turbuhaler in Asthma - Clinical Trials Registry . . .
    Main Inclusion Criteria: Participant must be 18 to 65 years of age inclusive with suitable veins for cannulation or repeated venepuncture Participants must have Physician-diagnosed mild asthma for at least 6 months prior to Screening Visit ≥ 70% predicted for FEV1 at the Screening Visit AND on Day -1
  • External validity of randomised controlled trials in asthma: to whom do . . .
    Exclusion criteria used were recent respiratory tract infection or asthma exacerbation in 13, potentially confounding use of drugs in 11, comorbid conditions in 9, more than a specified amount of smoking in 7, pregnant or lactating female participants in 5 and other exclusion criteria in 6 RCTs
  • Table 3, Inclusion and exclusion criteria - Intermittent Inhaled . . .
    If data cannot be abstracted after the first period, the trial will be included based on the following criteria, to minimize carry-over effects: for ICS -if the washout period is at least 6 weeks, 30 for LABA or LAMA - if the washout period is at least 4 weeks 31
  • Inclusion and exclusion criteria | Download Table - ResearchGate
    Selection criteria: We included parallel randomised controlled trials (RCTs) of adults or children with asthma that compared remote check-ups conducted using any form of technology versus
  • Table 1, Summary of inclusion and exclusion criteria - Shared Medical . . .
    “Exposure” must meet all the following criteria: A series of medical visits (at least two) where at least one health care professional (including a prescribing clinician a ) cares for a groups of patients
  • AZD4604 in Asthma - Clinical Trials Registry - ICH GCP
    Researchers look for people who fit a certain description, called eligibility criteria Some examples of these criteria are a person's general health condition or prior treatments Inclusion Criteria: Documented physician-diagnosed asthma ≥ 12 months prior to screening (Visit 1)





中文字典-英文字典  2005-2009